Institutional investors purchased a net $5.0 million shares of IPXL during the quarter ended December 2014 and now own 91.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SOUND POINT CAPITAL MANAGEMENT L... Bought 85.2 Thousand shares of Impax Laboratories Inc